Vilazon-40 Tablet

About Vilazon-40 Tablet

Vilazon-40 is a 40 mg tablet from Renata PLC containing vilazodone hydrochloride. It is an atypical antidepressant that doctors prescribe for major depressive disorder in adults.

There are 3 brands of Vilazodone Hydrochloride listed in Bangladesh.

What is Vilazon-40 Tablet?

Vilazon-40 is a prescription tablet made by Renata PLC. Its active ingredient is vilazodone hydrochloride, 40 mg in each tablet, and it belongs to a group called atypical antidepressants. Doctors use it to treat major depressive disorder in adults. Vilazodone is thought to work by increasing serotonin activity in the brain, though the exact way it lifts depression is not fully understood. Because it affects serotonin and other brain chemicals, it can interact with other medicines and needs medical supervision. Only a qualified doctor should decide whether it is suitable for you.

Uses of Vilazon-40

Vilazon-40 is intended for adults with major depressive disorder, a condition where low mood and loss of interest persist and interfere with daily life. It is not a general mood booster and should not be started without a doctor's assessment. A doctor will confirm the diagnosis and decide if this medicine is appropriate, and will also check for other conditions that may need different treatment.

How to use Vilazon-40

This tablet is taken by mouth, and the doctor decides the dose and how long you take it. Your doctor will explain whether to take it with food and how to follow the schedule. Do not change the dose or stop on your own, because stopping suddenly can cause problems. If you miss a dose, ask your doctor or pharmacist what to do rather than doubling up.

Side effects of Vilazon-40

Like all antidepressants, Vilazon-40 can cause unwanted effects. Serious risks that need medical attention include suicidal thoughts and behaviour, especially in young people, serotonin syndrome, increased bleeding risk, activation of mania or hypomania, withdrawal symptoms on stopping, seizures, angle-closure glaucoma, low sodium in the blood, and sexual problems. Tell your doctor promptly about any new or worsening symptoms, unusual bleeding, agitation, or eye pain, and seek urgent help if you feel unsafe.

Safety and precautions

Before starting Vilazon-40, tell your doctor about all medicines you take, including aspirin, pain relievers, blood thinners and other antidepressants, as combinations can raise the risk of bleeding or serotonin syndrome. Do not take it with monoamine oxidase inhibitors or within the period your doctor advises after stopping them. Tell your doctor if you have bipolar disorder, seizures, glaucoma, or kidney or liver problems. If you are pregnant, planning pregnancy or breastfeeding, ask your doctor first; there is a pregnancy registry for antidepressants and little is known about passage into breast milk. Keep all appointments for monitoring.

Frequently asked questions

What kind of medicine is Vilazon-40 and what is it used for?

Vilazon-40 is an atypical antidepressant tablet containing vilazodone hydrochloride 40 mg. Doctors use it to treat major depressive disorder in adults. It affects serotonin activity in the brain. It is a prescription medicine, so a doctor must confirm that it is right for you before use.

How should Vilazon-40 be taken?

Take the tablet by mouth exactly as your doctor directs. The doctor decides the dose, whether it is taken with food, and how long the course lasts. Never change the dose or stop suddenly without medical advice, and ask your doctor or pharmacist if you miss a dose.

How should Vilazon-40 be stored?

Store the tablets below 30°C, away from light and moisture, and keep them out of the reach of children. Keep them in the original packaging and do not use them after the expiry date. If you are unsure about storage, ask your pharmacist.

Who should check with a doctor before taking Vilazon-40?

Anyone who is pregnant, planning pregnancy or breastfeeding should speak to a doctor first. Also tell your doctor about bipolar disorder, seizures, glaucoma, liver or kidney problems, and every other medicine you take, including pain relievers and blood thinners, so the risks can be assessed.

Indications

Vilazodone Hydrochloride is indicated for the treatment of major depressive disorder (MDD) in adults.

Pharmacology

The mechanism of action of vilazodone in the treatment of major depressive disorder is not fully understood, but is thought to be related to its enhancement of serotonergic activity in the CNS through selective inhibition of serotonin reuptake. Vilazodone is also a partial agonist at serotonergic 5-HT1A receptors; however, the net result of this action on serotonergic transmission and its role in vilazodone’s antidepressant effect are unknown.

Dosage & Administration

Dosage for Treatment of Major Depressive Disorder: The recommended target dosage for vilazodone is 20 mg to 40 mg orally once daily with food. To achieve the target dosage, titrate vilazodone as follows:
  • Start with an initial dosage of 10 mg once daily with food for 7 days,
  • Then increase to 20 mg once daily with food.
  • The dose may be increased up to 40 mg once daily with food after a minimum of 7 days between dosage increases.
If a dose is missed, it should be taken as soon as the patient remembers. If it is almost time for the next dose, the patient should skip the missed dose and take the next dose at the regular time. Two doses should not be taken at the same time.

Screen for Bipolar Disorder Prior to Starting vilazodone: Prior to initiating treatment with vilazodone or another antidepressant, screen patients for a personal or family history of bipolar disorder, mania, or hypomania.

Switching to or from a Monoamine Oxidase Inhibitor Antidepressant: At least 14 days must elapse between discontinuation of a monoamine oxidase inhibitor (MAOI) antidepressant and initiation of vilazodone. In addition, at least 14 days must elapse after stopping vilazodone before starting an MAOI antidepressant.

Dosage Adjustments with CYP3A4 Inhibitors or Inducers:
  • Patients receiving concomitant CYP3A4 inhibitors: During concomitant use of a strong CYP3A4 inhibitor (e.g., itraconazole, clarithromycin, voriconazole), the vilazodone dose should not exceed 20 mg once daily. The original vilazodone dose level, can be resumed when the CYP3A4 inhibitor is discontinued.
  • Patients receiving concomitant CYP3A4 inducers: Based on clinical response, consider increasing the dosage of vilazodone by 2-fold, up to a maximum 80 mg once daily, over 1 to 2 weeks in patients taking strong CYP3A4 inducers (e.g., carbamazepine, phenytoin, rifampin) for greater than 14 days. If CYP3A4 inducers are discontinued, gradually reduce the vilazodone dosage to its original level over 1 to 2 weeks.
Discontinuing Treatment with vilazodone: Adverse reactions may occur upon discontinuation of vilazodone. A gradual reduction in dosage rather than abrupt cessation is recommended whenever possible. vilazodone should be down tapered from the 40 mg once daily dose to 20 mg once daily for 4 days, followed by 10 mg once daily for 3 days. Patients taking vilazodone 20 mg once daily should be tapered to 10 mg once daily for 7 days.

Interaction

CYP3A4 Inhibitors: The vilazodone dose should not exceed 20 mg once daily when coadministered with strong CYP3A4 inhibitors.

CYP3A4 Inducers: Consider increasing vilazodone dosage by 2-fold, up to 80 mg once-daily over 1 to 2 weeks when used concomitantly with strong CYP3A4 inducers for greater than 14 days).

Contraindications

Vilazodone is contraindicated in patients taking, or within 14 days of stopping, monoamine oxidase inhibitors (MAOIs), including MAOIs such as linezolid or intravenous methylene blue, because of an increased risk of serotonin syndrome.

Side Effects

  • Suicidal Thoughts and Behaviors in Adolescents and Young Adults
  • Serotonin Syndrome
  • Increased Risk of Bleeding
  • Activation of Mania or Hypomania
  • Discontinuation Syndrome
  • Seizures
  • Angle-Closure Glaucoma
  • Hyponatremia
  • Sexual Dysfunction

Pregnancy & Lactation

There is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to antidepressants during pregnancy. There are no data on the presence of vilazodone in human milk, the effects of vilazodone on the breastfed infant, or the effects of the drug on milk production. 

Precautions & Warnings

Serotonin Syndrome: Increased risk when co-administered with other serotonergic agents (e.g., SSRI, SNRI, triptans, amphetamines), but also when taken alone. If it occurs, discontinue vilazodone and initiate supportive treatment.

Increased Risk of Bleeding: Concomitant use of aspirin, nonsteroidal anti-inflammatory drugs (NSAIDs), other antiplatelet drugs, warfarin, and other anticoagulants may increase this risk.

Activation of Mania/Hypomania: Screen patients for bipolar disorder.

Seizures: Can occur with treatment. Use with caution in patients with a seizure disorder.

Angle Closure Glaucoma: Avoid use of antidepressants, including vilazodone, in patients with untreated anatomically narrow angles.

Sexual Dysfunction: vilazodone may cause symptoms of sexual dysfunction.

Storage Conditions

Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.

Alternative brands of Vilazodone Hydrochloride

Other brands with the same generic name, cheapest first.

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.